Eksponering for valsartan er ikke korreleret med graden af leverdysfunktion, selv om leversygdom øgede plasma AUC for valsartan.
Exposure to valsartan is not correlated with the degree of liver dysfunction, although the presence of liver disease tended to increase the valsartan plasma AUC.